Treatment of Psychotic Major Depression With Mifepristone
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Affective Disorders, Psychotic, Depressive Disorder
In brief
The purpose of this research study is to see how certain hormones cause changes in mood and thinking in some depressed patients and to determine the effectiveness of mifepristone in treating some forms of depression. This study is conducted in conjunction with an observational study "Clinical and Biological Characteristics of Psychotic Depression".
Key facts
- Study ID
- NCT00867360
- Run by
- Stanford University
- People needed
- 10
- Starts
- 2005-08-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2017-04-04
Who can join
Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.